Appraisals - ASAR & FAR

25/07/2019

Final Recommendation: telotristat ethyl (Xermelo) 2037

25/07/2019

Final Recommendation: ciprofloxacin (Cetraxal) 1343

04/01/2022

Final Recommendation: icatibant acetate (Firazyr) 3293

04/01/2022

Final Recommendation: dabigatran etexilate (Pradaxa) 2293

04/01/2022

Final Recommendation: rivaroxaban (Xarelto) 3875

04/01/2022

Final Recommendation: clostridium botulinum (Xeomin) 3986

04/01/2022

Final Recommendation: cannabidiol (Epidyolex) 3201

04/01/2022

Final Recommendation: ustekinumab (Stelara) 3687

04/01/2022

Final Recommendation: glecaprevir / pibrentasvir (Maviret) 4917

03/02/2020

Final Recommendation: adalimumab (Humira) 5

12/10/2021

Final Recommendation: amikacin (Arikayce) 2140

12/10/2021

Final Recommendation: dolutegravir (Tivicay) 4611

12/10/2021

Final Recommendation: nitisinone (Orfadin) 2322

12/10/2021

Final Recommendation: everolimus (Votubia) 2142

12/10/2021

Final Recommendation: etravirine (Intelence) 4506

01/08/2019

Final Recommendation: ulipristal acetate (Esmya) 2767

27/05/2021

Final Recommendation: conestat alfa (Ruconest) 4519

27/05/2021

Final Recommendation: perampanel (Fycompa) 4770

27/05/2021

Final Recommendation: indacaterol (Enerzair Breezhaler) 3141

17/05/2021

Final Recommendation: buprenorphine naloxone (Suboxone) 4590